Pharma goes digital: Prospects for the “Medicine-as-a-Service” paradigm
Public lecture by Dr. Jody Ranck
Time: Monday 20th of April, at 10.
Venue: Biomedicum 1, lecture hall 3.
Abstract
The pharmaceutical and life sciences industry is in the early days of a major transformation of business models. The end of the blockbuster drug era, generic medications, chronic diseases and the shift to value-based care for reimbursements means pharmaceutical companies must adapt to a radically changing environment in the coming years.
While historically risk averse, pharma is now beginning to embrace the digital health era. The first wave of digital health experiments in pharma were more direct to consumer marketing apps but robust digital health platforms will be the future. This new paradigm, characterized as “Medicine-as-a-Service” will no longer have the medication as the sole focus, but rather look for ways to leverage deep data analytics capabilities, risk management and relationships with doctors and patients into the next wave of digital health platforms for prevention and chronic disease management at a moment when the major technology platforms from Apple to Google are also entering the picture.
We may see new configurations of technologies, platforms and business models that offer new alignments of cooperation and competition in the coming years.
Biographical note
Dr. Jody Ranck has over 25 years of global experience in healthcare and is the author of a recent book, “Connected Health: How Mobiles, Cloud and Big Data will Reinvent Healthcare” and his second book will be on “Disruptive Cooperation in Digital Health”. He is the co-CEO of Unison Health, a data-driven startup that is a coordinated care platform for patients and providers and the Vice President of Strategy and Business Development for Swiss healthbank. He has consulted widely across the insurance industry, startups, management consulting, think tanks, design firms and the telecommunications industry on strategy, innovation and partnerships. His Digital Health consulting practice works with PwC, the French Tech Hub, Data Guild, a data analytics firm. In the past he has held executive roles with the mHealth Alliance, Institute for the Future, InSTEDD and worked at the Grameen Bank in Bangladesh. He holds a doctorate from the University of California, Berkeley in Health Policy and Administration, an MA in International Relations and Economics from Johns Hopkins University, School of Advanced International Studies as well as a BA in Biology (Molecular Biology) from Ithaca College.
The lecture is sponsored by the Digital Health Revolution research consortium funded by Tekes.
<$DetailsLisatietojaLinkki$>
<$DetailsTakaisinHakutuloksiin$>